6th Annual Cell Engager Summit, Boston, MA, May 21-23, 2024

Conference

genOway presentation

Event
-
May 21, 2024

May 21-23, 2024

Advancing the Development of Novel Targets, Safe & Effective Multi-Specific Immune Cell Engagers for Solid & Liquid Tumors in the Clinic

‍

‍

genOway's presentation on May 22, 2024 | 11:30 a.m. EDT:

How to Enhance Translatability of Immunotherapies in Preclinical Models?

  • Focus on syngeneic humanized mouse models and BRGSF-HIS hCD34+ reconstituted mice featuring human lymphoid and myeloid compartments
  • Characterization of the immune response in the mice
  • Assessment of efficacy and safety induced by cell engagers

6th Annual Cell Engager Summit, Boston, MA, May 21-23, 2024

Get in touch

Let us know how we can help

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
18th annual PEGS Europe, Lisbon, Portugal, November 16-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tukuba, Japan, November 16-19, 2026
Conference
Event
-
Nov 2026
Read on
SITC meeting 2026, Phoenix, Arizona, November 4-8
Conference
genOway presentation
Event
-
Nov 2026
Read on
2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe